Skip to main content

Table 2 Correlations between the expression level of Bmi-1 or Mel-18 and clinical-pathologic variables

From: Expression and clinicopathological significance of Mel-18 and Bmi-1 mRNA in gastric carcinoma

Variable

Bmi-1

Mel-18

 

n

GA

P

n

GA

P

Gender

      

   Male

58

1.568

0.687

58

0.259

0.309

   Female

13

1.958

 

13

0.150

 

Age(years)

      

   <60

44

1.584

0.832

44

0.188

0.166

   ≥60

27

1.715

 

27

0.336

 

Size (cm)

      

   <4.5

26

0.965

0.049*

26

0.206

0.335

   ≥4.5

45

2.213

 

45

0.313

 

Histology

      

   Moderately differentiated

13

0.989

0.248

13

0.185

0.584

   Poorly differentiated

58

1.827

 

58

0.247

 

T classification

      

   T1/2

12

0.635

0.036*

12

0.399

0.242

   T3/4

59

1.979

 

59

0.210

 

LNM

      

   Negative

16

0.762

0.044*

16

0.513

0.037*

   Positive

55

2.038

 

55

0.186

 

Distant metastasis

      

   Negative

68

1.663

0.597

68

0.232

0.645

   Positive

3

2.932

 

3

0.372

 

Clinical Stage

      

   I/II

22

0.949

0.075

22

0.506

0.010*

   III/IV

49

2.084

 

49

0.166

 
  1. Abbreviations: LNM, lymph node metastases; GA, geometrical average; *, Statistically significant. Statistically significant at 0.05 level (bilateral).
Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us